Has Luke Kim, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,397 in general payments to Luke Kim, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Luke Kim, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Luke Kim, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Luke Kim, MD

Interventional Cardiology · New York, NYNPI 1801053632

Payments from drug & device makers

$16,397in general payments, 2019–2025

Across 123 payments — averaging $133.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$3K
Shockwave Medical, Inc$3K
Medtronic$3K
Abbott$2K
Boston Scientific$1K
Teleflex LLC$1K
plus $3K from 8 others

What the payments were for

Consulting fees$4,73429%
Food & beverage$11,50470%
Education$1591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	2	$3,134
Shockwave Medical, Inc	16	$2,934
Medtronic(2 entities)	28	$2,661
Abbott	35	$1,818
Boston Scientific	9	$1,326
Teleflex LLC	1	$1,200
Philips North America LLC	8	$849
Spectrawave, Inc	4	$787
Abiomed	7	$773
Endologix LLC	7	$385
Edwards Lifesciences	2	$288
Siemens Medical Solutions USA, Inc.	2	$191
Terumo Medical Corporation	1	$26
Scpharmaceuticals Inc.	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$2,934
MANTA$1,200
Abre$945
Impella$720
HyperVue Imaging System$706
Starlight Imaging Catheter$706
Resolute$625
Xience Sierra Coronary Stent System$483
AVVIGO$400
SAPIEN 3 Ultra RESILIA$288
(6574) Coronary Other$276
ENDOCROSS Device$259
Torus Stent Graft System$259
AMPLATZER$226
CoreValve Evolut$180
ROTAPRO$174
AVVIGO Guidance System$174
COREVALVE EVOLUT R$170
(V057) Refinity$159
ACUSON Origin Diagnostic Ultrasound System$158

How this compares

$16,397 in reported general payments places this provider in the 55th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024

$258,615

Medicare patients

504

Services billed

1,396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	69	$52,314
Repatha SureclickEvolocumab	12	$16,328
Ranolazine ErRanolazine	29	$1,520
Metoprolol Succinate	89	$1,055
Rosuvastatin Calcium	51	$810
Ezetimibe	37	$651
Atorvastatin Calcium	91	$642
ClopidogrelClopidogrel Bisulfate	51	$509
Carvedilol	33	$315
Simvastatin	15	$288
Lisinopril	55	$275
Amlodipine Besylate	37	$223
Losartan Potassium	21	$108
Pravastatin Sodium	14	$108
Furosemide	14	$96

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in New York

Martin LeonNew York$13.5M
Susheel KodaliNew York$6M
Deepak BhattNew York$4.1M
Samin SharmaNew York$3.7M
Annapoorna KiniNew York$3.5M
Sahil ParikhNew York$2.7M
George DangasNew York$2.6M
Prakash KrishnanNew York$2M
Ajay KirtaneNew York$1.8M
Shing-Chiu WongNew York$1.5M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →